Scenarios that move CORT

Corcept Therapeutics Incorporated - Common Stock

Scenarios that move CORT: 1 analysis, 1 positive, 0 negative.

  1. · CHMP backs CORT's Lifyorli combo for ovarian cancer — ▲ · impact +85 · confidence high · horizon immediate

All scenarios · Run a scenario · Pricing